After surviving pancreatic cancer, a patient learns the disease metastasized to his liver. But this patient was not ready to give up. With the support of a liver surgeon, he underwent surgery and beat his disease.
Legislation passed in 2003 intended to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has not proved to be a success.
A retrospective study has uncovered an overuse of colonoscopies for colorectal cancer screening and surveillance.
A recent review has found insufficient consistent data exist to recommend a change in use of levothyroxine as the only drug needed to treat hypothyroidism.
Researchers designed a collaborative approach in cancer care that decreased the number of patients readmitted.
Patients who know individual risk for colorectal cancer are not sufficient to convince previously nonadherent patients.
Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.
Ann J. Brady, MSN, RN-BC
Jiajoyce Conway, DNP, FNP-BC, AOCNP, NP-C
Frank dela Rama, RN, MS, AOCNS
Marianne Davies, DNP, ACNP, AOCNP
Donald R. Fleming, MD
Karen MacDonald, RN, BSN, CPON
Susanne Menon, MP, OCN
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|